0 - 0

Directory Details

Al Amal Hospital Laboratory Pure Health Group

Initial Accreditation Date:Jan 08 , 2020

Contacts Info

Address

Dubai, United Arab Emirates

PO box / Zip Code

0

Email

hawraa.allowatia@purelab.com

Website

www.purehealth.ae

Main Field

Medical Laboratories

Valid Since:Apr 27 , 2026

Type of Biological Sample Components / Analytes Examination Technique Examination Procedure Status
Biochemistry
  • EDTA Plasma
  • Methamphetamine
  • Competitive Chemiluminescent Immunoassay on Biochip Array system (Randox Multistat Evidence SN: 052-22-0286)
PL-CLC-PR-211Active
  • Barbiturates
PL-CLC-PR-211Active
  • Benzodiazepin-1
PL-CLC-PR-211Active
  • Benzodiazepine-2
PL-CLC-PR-211Active
  • Methadone
PL-CLC-PR-211Active
  • Opiates
PL-CLC-PR-211Active
  • Phencyclidine
PL-CLC-PR-211Active
  • Benzoylecgonline
PL-CLC-PR-211Active
  • Oxycodone
PL-CLC-PR-211Active
  • Tramadol
PL-CLC-PR-211Active
  • THC- Cannabinoids
PL-CLC-PR-211Active
  • Amphetamine
PL-CLC-PR-211Active
  • Buprenorphine
PL-CLC-PR-211Active
  • 6MAM
PL-CLC-PR-211Active
  • Synthetic Cannabinoids- JWH-018
PL-CLC-PR-211Active
  • ALPHAPVP
PL-CLC-PR-211Active
  • Synthetic Cannabinoids- UR 144
PL-CLC-PR-211Active
  • Heparinized Plasma/ Serum
  • Alanine Aminotransferase
  • UV with P5P - IFCC (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-011Active
  • Albumin
  • Bromcresol Purple (BCP)(Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-012Active
  • Alkaline Phosphatase
  • PNPP, AMP Buffer - IFCC (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-013Active
  • Aspartate Aminotransferase
  • Enyzmatic- P5P - IFCC (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-047Active
  • Chloride
  • Indirect ISE (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-036Active
  • Creatinine
  • Alkaline picrate−kinetic, IFCC−IDMS Standardized (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-021Active
  • Creatine Kinase
  • Enzymatic, NAC Activated - IFCC (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-007Active
  • Potassium
  • Indirect ISE (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-036Active
  • Protein, Total
  • Biuret, serum blank, endpoint (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-003Active
  • RCRP
  • Immunoturbidimetry (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-020Active
  • Sodium
  • Indirect ISE (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-036Active
  • Troponin-I High Sensitive (TNIH)
  • Sandwich Chemiluminescent immunoassay (Dimension EXL 200, S.No.DR270645)
PHL-CLC-PR-001Active
  • Urea
  • Urease, UV (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-042Active
  • Uric Acid
  • Uricase, UV (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-043Active
  • Plasma/Serum
  • Amylase
  • Enzymatic, CNP−triose/CNPG3 (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-015Active
  • Bicarbonate
  • Enzymatic, PEP (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-033Active
  • Serum/Heparinized Plasma/EDTA Plasma
  • Bilirubin, Total
  • Diazotization (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-037Active
  • Heparinized Plasma/ Serum / EDTA Fluride
  • Glucose
  • Hexokinase (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-027Active
  • Heparinized Plasma
  • Gamma Glutamyl Transferase
  • G−glutamyl−carboxy−nitroanilide - IFCC (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-025Active
  • Heparinized Plasma/ Serum / EDTA Fluride
  • Estimated Glomerular Filtration Rate (eGFR)
  • Calculated (Dimension EXL 200, S.No.DR270645)
PL-CLC-PR-021Active
  • Urine
  • Benzodiazipines
  • Enzyme Immunoassay technique (Viva Pro E, S.No. 14-1320)
PL-CLC-PR-059Active
  • AMPHETAMINE
PL-CLC-PR-056Active
  • Opiates
PL-CLC-PR-057Active
  • COCAINE
PL-CLC-PR-058Active
  • Cannabinoid
PL-CLC-PR-061Active
  • METHADONE
PL-CLC-PR-062Active
  • MDMA (Ecstasy)
PL-CLC-PR-207Active
  • BARBITURATES
PL-CLC-PR-205Active
  • Phencyclidine
PL-CLC-PR-208Active
  • BUPRENORPHINE
  • Enzyme Immuno Assay (Viva Pro E, S.No. 14-1320)
PL-CLC-PR-206Active
  • Capillary Blood/Finger prick
  • Glucose
  • Electrochemical Method (I Sens Caresens Expert Plus CPT1190K0033)
PL-POCT-IN-002Active
  • EDTA Plasma
  • Fentanyl
  • Competitive Chemiluminescent Immunoassay on Biochip Array system (Randox Multistat Evidence SN: 052-22-0286)
PL-CLC-PR-211Active
  • Ketamine
PL-CLC-PR-211Active
  • LSD
PL-CLC-PR-211Active
  • Methamphetamine
PL-CLC-PR-211Active
  • Barbiturates
PL-CLC-PR-211Active
  • Benzodiazepin-1
PL-CLC-PR-211Active
  • Benzodiazepine-2
PL-CLC-PR-211Active
  • Methadone
PL-CLC-PR-211Active
  • Opiates
PL-CLC-PR-211Active
  • Phencyclidine
PL-CLC-PR-211Active
  • Benzoylecgonline
PL-CLC-PR-211Active
  • Oxycodone
PL-CLC-PR-211Active
  • Tramadol
PL-CLC-PR-211Active
  • THC- Cannabinoids
PL-CLC-PR-211Active
  • Amphetamine
PL-CLC-PR-211Active
  • Buprenorphine
PL-CLC-PR-211Active
  • 6MAM
PL-CLC-PR-211Active
  • Synthetic Cannabinoids- JWH-018
PL-CLC-PR-211Active
  • Synthetic Cannabinoids- UR 144
PL-CLC-PR-211Active
Haematology
  • Citrated Plasma
  • Prothrombin Time (PT)
  • Photo-Optical Clot Detection Method
PL-HEM-IN-002Active
  • Activated Partial Thromboplastin Time (APTT)
PL-HEM-IN-002Active
  • EDTA Whole Blood
  • Hematocrit
  • Calculated
PL-HEM-IN-003 Advia 560Voluntary withdrawal
Since May 22, 2026
  • MCV
PL-HEM-IN-003 Advia 560Voluntary withdrawal
Since May 22, 2026
  • MCH
PL-HEM-IN-003 Advia 560Voluntary withdrawal
Since May 22, 2026
  • MCHC
PL-HEM-IN-003 Advia 560Voluntary withdrawal
Since May 22, 2026
  • RDW cv
PL-HEM-IN-003 Advia 560Voluntary withdrawal
Since May 22, 2026
  • MPV
PL-HEM-IN-003 Advia 560Voluntary withdrawal
Since May 22, 2026
  • Neutrophil Absolute Count
PL-HEM-IN-003 Advia 560Withdrawn
Since May 22, 2026
  • Lymphocyte Absolute Count
PL-HEM-IN-003 Advia 560Withdrawn
Since May 22, 2026
  • Monocyte Absolute Count
PL-HEM-IN-003 Advia 560Withdrawn
Since May 22, 2026
  • Eosinophil Absolute Count
PL-HEM-IN-003 Advia 560Withdrawn
Since May 22, 2026
  • Basophil Absolute Count
PL-HEM-IN-003 Advia 560Withdrawn
Since May 22, 2026
  • WBC
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • RBC
  • Sheath Flow Impedance Method
PL-HEM-IN-028Active
  • Hemoglobin
  • Colorimetric Method
PL-HEM-IN-028Active
  • Hematocrit
  • Calculated
PL-HEM-IN-028Active
  • MCV
PL-HEM-IN-028Active
  • MCH
PL-HEM-IN-028Active
  • MCHC
PL-HEM-IN-028Active
  • Platelet
  • Sheath Flow Impedance Method
PL-HEM-IN-028Active
  • RDW cv
  • Calculated
PL-HEM-IN-028Active
  • MPV
PL-HEM-IN-028Active
  • Neutrophil %
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • Neutrophil Absolute Count
  • Calculated
PL-HEM-IN-028Active
  • Lymphocyte %
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • Lymphocyte Absolute Count
  • Calculated
PL-HEM-IN-028Active
  • Monocyte %
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • Monocyte Absolute Count
  • Calculated
PL-HEM-IN-028Active
  • Eosinophi %
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • Eosinophil Absolute Count
  • Calculated
PL-HEM-IN-028Active
  • Basophil %
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • Basophil Absolute Count
  • Calculated
PL-HEM-IN-028Active
  • NRBC #
  • SF Cube Cell Analysis Technology
PL-HEM-IN-028Active
  • NRBC %
PL-HEM-IN-028Active
Biochemistry - POCT (MAH-Male Acute Ward-1DETOX, Female Intellectual Disability Rehablitation Villa B, Female Forensic Ward,Acute female Ward-3, Female Rehablitation Villa C, MAH-Male Acute Ward-4,Male Rehablitation Villa E, Female Acute Ward-2, Male
  • Capillary Blood/Finger prick
  • Glucose
  • Electrochemical Method (I Sens Caresens Expert Plus I Sens Caresens Expert PlusCPT1340H0040, CPT1011K0011CPT1190K0036, CPT1340H0035CPT1235H0049, CPT1190K0047CPT1013J0036, CPT1235H0066CPT1190K0015, CPT1065J0091CPT1235H0048, CPT1235H0012CPT1235H0070, C
PL-POCT-IN-002Active